Wolverine Trading
ANIP icon

Wolverine Trading’s ANI Pharmaceuticals ANIP Stock Holding History

Wolverine Trading’s Portfolio ANIP Stock Details ANIP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-7,278
Closed -$462K – 5070
2017
Q4 		$469K Buy
+7,278
New +$453K ﹤0.01% 3076
2017
Q3 		– Sell
-6,554
Closed -$309K – 4371
2017
Q2 		$309K Buy
6,554
+2,289
+54% +$110K ﹤0.01% 2996
2017
Q1 		$212K Sell
4,265
-1,429
-25% -$80.2K ﹤0.01% 3457
2016
Q4 		$345K Buy
+5,694
New +$348K ﹤0.01% 3089

Other funds holding ANIP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
GACM
Global Alpha Capital Management Montreal, Quebec, Canada $1.67B AUM 35.09% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Wolverine Trading's ANIP Position: Q1 2018 in Review

Wolverine Trading sold out of ANI Pharmaceuticals (ANIP) in Q1 2018, closing a stake of 7,278 shares — an estimated $462K sold.

Wolverine Trading first reported a position in ANIP in Q4 2016 and held it in 4 quarters. The position peaked at $469K in Q4 2017. 175 funds tracked by Wall St. Rank hold ANIP as of Q1 2018.

  • Wolverine Trading reported no remaining ANI Pharmaceuticals position as of Q1 2018 after selling out during the quarter.
  • Wolverine Trading sold 7,278 ANI Pharmaceuticals shares in Q1 2018, an estimated $462K.
  • Wolverine Trading first reported a position in ANI Pharmaceuticals in Q4 2016 and held it in 4 quarters.
  • Wolverine Trading's ANI Pharmaceuticals position peaked at $469K in Q4 2017.
  • 175 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q1 2018.

Based on Wolverine Trading's 13F filing for Q1 2018, filed 15 May 2018.